Managed Access Programs for EXV811, Atrasentan
- Status
- AVAILABLE
- Phase
- N/A
Clinical Trials Related to Atrasentan
Related studies linked through entity extraction aliases.
Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy
- Status
- COMPLETED
- Phase
- PHASE2
Atrasentan in Patients With Proteinuric Glomerular Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Atrasentan in Patients With IgA Nephropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Atrasentan Spermatogenesis and Testicular Function
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Diabetic Nephropathy With Atrasentan
- Status
- TERMINATED
- Phase
- PHASE3
A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Correlation of Endothelial Function and Early Coronary Artery Disease in Humans
- Status
- COMPLETED
- Phase
- PHASE3
Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone
- Status
- COMPLETED
- Phase
- PHASE2
A Long Term Safety Study With Atrasentan
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
- Status
- COMPLETED
- Phase
- PHASE2
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3